JPM26: What’s in a biopharma? CEO says Teva has the goods In 2023, Teva made a pledge to bolster its innovative medicines portfolio without leaving behind its century-long legacy as a leading generics drugmaker. | Under CEO Richard Francis, Teva has long bee...

#JPM26 #biopharma #Teva #TevaPharmaceuticals #RichardFrancis #innovativemedicines #generics #biopharmaidentity #PivottoGrowth #RoyaltyPharma #TEV408 #vitiligo #phase2bstudy #genericmedicines #schizophrenia #olanzapine #Uzedy #longactingmedication #biosimilars #biosimilarmarket
zurl.co/ErF5t

Time to emphasise the economics in health economics Victoria Jordan, ABPI Value and Access Policy Director, discusses the Health Economics of the UK-US Economic Prosperity Deal and the commitment to increase NICE's baseline threshold use, the first cha...

#ABPI #NICE #UKUSEconomicProsperityDeal #innovativemedicines #populationhealth #pharmaceuticalindustry #VPAG #StatutorySchemerebates #priceofmedicines #NHSindustrypartnerships #GVA #RandD #UKResearchandInnovation #clinicaltrials #UKmedicineexports #brandedmedicines #NICEthreshold
zurl.co/D8SUt

UK-US deal is good news for NHS patients and will help to support UK life sciences competitiveness, says ABPI Industry hopes the new trade agreement will allow more innovative medicines to reach a greater number of NHS patients and will be a positive step in supporting the UK life sciences industry.

#ABPI #UKUStradedeal #lifesciences #PharmaIndustry #innovativemedicines #UKlifesciencesindustry #lifesciencesinvestment #lifesciencesresearch #pharmaceuticalexports #VPAG #VPAGscheme #NICEthreshold #patientaccess #healthoutcomes #lifescienceinvestment #NHSaccesstomedicines
zurl.co/vi7Md

Britain prepares NHS drug spending hike to stave off Trump tariffs Officials briefed the Trump administration on fresh proposals for pharma pricing earlier this week.

#PharmaIndustry #PharmaInvestment #Medicines #patientaccess #TrumpTariffs #NHS #Britain #NHSdrugspending #pharmapricing #NICE #NICEthreshold #pharmaceuticalimports #AstraZeneca #GSK #innovativemedicines #PlanforChange #LifeSciencesSectorPlan #pharmaceuticalexports
www.politico.eu/article/brit...

Pharma tariffs yet to emerge as Trump seeks more deals Donald Trump looks set to delay the introduction of his tariffs on pharma imports in order to negotiate more deals with drugmakers on drug pricing.

#pharmanews #pharmaindustry #Pharmatariffs #Trump #tariffrates #pharmaceuticalimports #drugpricing #Pfizer #mostfavourednationpolicy #MFNpolicy #TrumpRx #directtoconsumer #MFNprices #innovativemedicines #PharmaceuticalRandD #Pharmaceuticalmanufacturing #EliLilly #pharmaspecificlevies
zurl.co/CG3Ji

UK life sciences plan falls short, says ABPI ABPI is warning that the core ambition of the government's new life sciences strategy will not be realised unless it makes a real commitment to invest more in new medicines.

#ABPI #lifesciencesplan #lifesciences #lifesciencesstrategy #lifesciencessector #pharmaceuticalindustry #RandD #investmentinmanufacturing #lifesciences #innovativemedicines #NHSpatients #patientaccess #healthoutcomes #VPAG #StatutoryScheme #medicalinnovation
www.abpi.org.uk/media/news/2...

FirstWord

#lifesciences #EFPIA #intellectualproperty #clinicaltrials #marketaccess #lifescienceinnovations #EUBiotechAct #biotech #biotechdevelopment #biotechinnovations #innovativemedicines #intellectualpropertyframework #pharmaceuticalRandD #ClinicalResearch
firstwordpharma.com/story/5977924

Be sure to check out our MM+M "Strategies for Success" podcast session at www.mmm-online.com/partnerconte... to hear how we're delivering on the promise of innovative medicines and the transformative impact of AI.

#InnovativeMedicines #TransformativeAI #PharmaMarketing

#Netherlands continues negative trend, sees further decline in drug wait time rankings The general manager of the Dutch #InnovativeMedicines Association described the figures as ‘alarming’.

#Netherlands continues negative trend, sees further decline in drug wait time rankings: The general manager of the Dutch #InnovativeMedicines Association described the figures as ‘alarming’.

Our CEO @PilarGIbez opens today's session on #funding of #InnovativeMedicines in the framework of #EENCanHelp #IncúbateFPCM